Disintegrator Products Receives OSHA Guidance on Use of its NDD for Needlestick Prevention

Article

BROADVIEW HEIGHTS, Ohio -- In a letter dated Nov. 17, 2003, the Occupational Safety and Health Administration (OSHA) acknowledged that the use of devices such as the Disintegrator PRO would comply with the requirements of the bloodborne pathogens regulations in appropriate settings. The product is manufactured by Safeguard Medical Devices, Inc., d.b.a. Disintegrator Products.

In response to a May 30, 2003 letter from the firm, OSHA stated, "The requirements of the standards are performance based" and that "compliance was determined on a facility-by-facility basis." OSHA further clarified that "Where SESIPs are not effective, available, or appropriate the employer must look at other means to reduce exposure . which would include a NDD (needle destruction device)."

According to OSHA's letter, the employer is to determine the most effective means of preventing accidental needlesticks, with input from non-managerial employees, and document the consideration and selection of the engineering control in their ECP (exposure control plan). Once the employer determines that an engineering control is effective, they are not required to evaluate all available new controls every year, but to simply keep abreast of new technologies and document this in their ECP.

With the push of a button, the compact PRO unit is designed to create a small plasma arc that literally melts the steel needle tip, leaving a blunt, sealed and safe endpoint. During the process, the needle tip is heated to approximately 3,000 degrees Fahrenheit, practically ensuring the elimination of any pathogens.

The lightweight unit operates from either ac current or the built-in rechargeable battery, and is FDA approved for use with most common needles, lancets and pre-filled vials.

The unit serves as an effective, inexpensive solution to the challenging problem of reducing needlestick exposure in many professional settings.

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content